The Ischemia Modified Albumin In Diagnosing Ischemic New Events (IMAGINE Study).
The Ischemia Modified Albumin In Diagnosing Ischemic New Events (IMAGINE Study).
The purpose of the study is to evaluate the utility of Ischemia Modified Albumin (IMA) for risk stratification in patients presenting with chest discomfort and possible ischemic heart disease, and to evaluate the diagnostic and prognostic implication for IMA for major adverse cardiac events.
Inclusion Criteria:
Exclusion Criteria: